You will be logged out in due to inactivity. Please click Ok to extend the session or select Log Out to end the session.
971 medical examiner and coroner offices participated in the most recent 2017 NFLIS-MEC Survey
Quantitative Analysis Frequency Reported as "Always" by Toxicology Laboratories, 2017 NFLIS-MEC Survey
During calendar year 2016,
human death cases were referred to responding MECs. Of these, 497,395 were accepted by MECs. On average, 888 human death cases were referred to MECs, and 395 cases on average were accepted.
2017 NFLIS-MEC Survey
IN 2016, MECs REPORTED "ALWAYS" CONDUCTING TOXICOLOGY TESTING FOR THE FOLLOWING DRUGS OR DRUG CLASSES MORE THAN 75% OF THE TIME:
In 2018, DEA expanded the NFLIS program to include two additional continuous drug surveillance components that collect drug-related mortality data from medical examiner and coroner offices (NFLIS-MEC) and drug testing results from toxicology laboratories (NFLIS-Tox) to supplement and complement the current NFLIS-Drug data from drug cases submitted to and analyzed by the Nation's forensic laboratories.
If your office would like to participate in NFLIS-MEC, please review DEA's FAQs document to determine your entity's eligibility to participate in NFLIS and to review other information about each NFLIS component and the next steps for participation. If you have any questions or would like to participate in NFLIS-MEC, please contact the NFLIS team at DEANFLIS@rti.org.
Although DEA does not expect to be able to publish NFLIS-MEC data in the immediate future, DEA has the results of the 2017 NFLIS-MEC Survey. The next administration of the NFLIS-MEC survey will be launched in 2022.